Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | DMAC | Voting Common Shares, no par value per share | 21.9K | Jul 15, 2021 | Direct | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | DMAC | Stock Option (right to buy) | Award | $0 | +9.39K | $0.00 | 9.39K | Jul 15, 2021 | Common Shares | 9.39K | $3.64 | Direct | F2 |
Id | Content |
---|---|
F1 | Includes 3,850 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan and 15,847 shares issuable upon settlement of deferred stock units granted under the DiaMedica Therapeutics Inc. 2019 Omnibus Incentive Plan. |
F2 | Vests in four nearly equal quarterly installments over one year. |